Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Supporting Rakuten Medical's efforts to accelerate its global Phase 3 study with the goal of achieving approval of ASP-1929 in US as soon as possible ...
Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary...
Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy treatments based on ...
Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting...
Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on...
Rakuten Medical, Inc., a global biotechnology company developing precision, cell-targeting therapies based on its proprietary photoimmunotherapy...
Mickey Mikitani, Co-CEO of Rakuten Medical, Inc. gave a presentation to investors from around the world at the 41st Annual J.P. Morgan Healthcare...
Rakuten Medical, Inc. (Rakuten Medical) has newly established its subsidiary in India, Rakuten Medical Private Limited (Rakuten Medical India) to...
Rakuten Medical Taiwan, Inc. today announced that their ASP-1929 Photoimmunotherapy Phase 2 clinical trial (ClinicalTrials.gov Identifier:...
Rakuten Medical, Inc. (Rakuten Medical) has elected to discontinue use of the name "Illuminox," and to start using a new, evolved name "Alluminox™"...
Rakuten Medical, Inc. (Rakuten Medical) and Shimadzu Corporation (Shimadzu) today announced enrollment of the first patient in the phase 2 clinical...
Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer...
Rakuten Medical, Inc today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND)...
Rakuten Medical, Inc. (Rakuten Medical) announced that data from a phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in...
Rakuten Medical Inc, and Karkinos Healthcare Private Limited announced a strategic collaboration to expand the reach of novel cancer care to India....
Rakuten Medical, Inc. today announced that it has appointed Nitin Nohria and Hiroshi Takasawa to the company's board of directors. Dr. Nohria will...
Rakuten Medical, Inc., a global clinical stage biotechnology company focused on developing and commercializing innovative oncology products for...
Rakuten Medical, Inc. (Rakuten Medical) announced that data from a phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese ...
Rakuten Medical, Inc. (HQ: San Mateo, Calif.; Chairman and CEO: Hiroshi Mikitani; hereinafter "Rakuten Medical") and Shimadzu Corporation (HQ: Kyoto, ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.